(Q62814189)

English

cAd3-Marburg Vaccine in Healthy Adults

clinical trial

Statements

RV 507: A Phase I Open-Label, Dose-Escalation Clinical Trial to Evaluate the Safety, Tolerability and Immunogenicity of the Marburg Chimpanzee Adenovirus Vector Vaccine, VRC-MARADC087-00-VP (cAd3-Marburg), in Healthy Adults (English)
0 references
10 October 2018
0 references
July 2019
0 references
40
0 references
18 year
0 references
50 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit